Literature DB >> 22592040

A randomized double-blind trial of upward progressive versus degressive compressive stockings in patients with moderate to severe chronic venous insufficiency.

Serge Couzan1, Alain Leizorovicz, Silvy Laporte, Patrick Mismetti, Jean-François Pouget, Céline Chapelle, Isabelle Quéré.   

Abstract

BACKGROUND: The present randomized double-blind multicenter study was designed to assess the efficacy of a progressive compressive stocking (new concept with maximal pressure at calf), compared to a degressive compressive stocking graded 30 mm Hg, evaluating the improvement of lower leg symptoms of chronic venous insufficiency (CVI) in ambulatory patients with moderate to severe chronic venous disease.
METHODS: Both gender outpatients presenting symptomatic moderate to severe CVI were eligible for a treatment by compressive stockings. Patients were randomly assigned to receive either degressive compressive stockings (30 mm Hg at ankle, 21 mm Hg at upper calf) or progressive compressive stockings (10 mm Hg at ankle, 23 mm Hg at upper calf). The primary outcome, evaluated after 3 months, was a composite success outcome, including improvement of pain or heavy legs without onset of either ulcer, deep or superficial vein thrombosis of the lower limbs, or pulmonary embolism. The ease of application of the compressive stockings reported by patients was one of secondary outcome.
RESULTS: Overall, 401 patients (199 in the progressive compressive stocking group and 202 in the degressive compressive stocking group) were randomized by 44 angiologists in France. Among them, 66% were classified in the C3 CEAP category. The rate of success was significantly higher in the progressive compressive stocking group compared to the degressive compressive stocking group (70.0% vs 59.6%; relative risk, 1.18; 95% confidence interval, 1.02-1.37; P = .03). This was mainly due to more frequent symptom improvement in the progressive compressive stocking group. The compressive stockings were considered easy to apply by 81.3% of patients in the progressive compressive stocking group vs 49.7% of patients in the degressive compressive stocking group (P < .0001). The rate of related serious adverse events was low and similar in both groups.
CONCLUSIONS: This trial has demonstrated that progressive compressive stockings are more effective than usual degressive compressive stockings in the improvement of pain and lower leg symptoms in patients with CVI. Moreover, progressive compressive stockings were easier to apply, raising no safety concern at 3 months.
Copyright © 2012 Society for Vascular Surgery. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22592040     DOI: 10.1016/j.jvs.2012.02.060

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  9 in total

Review 1.  [Medical compression therapy of the extremities with medical compression stockings (MCS), phlebological compression bandages (PCB), and medical adaptive compression systems (MAC) : S2k guideline of the German Phlebology Society (DGP) in cooperation with the following professional associations: DDG, DGA, DGG, GDL, DGL, BVP. German version].

Authors:  E Rabe; E Földi; H Gerlach; M Jünger; G Lulay; A Miller; K Protz; S Reich-Schupke; T Schwarz; M Stücker; E Valesky; F Pannier
Journal:  Hautarzt       Date:  2021-02       Impact factor: 0.751

2.  Venous leg ulcer management in clinical practice in the UK: costs and outcomes.

Authors:  Julian F Guest; Graham W Fuller; Peter Vowden
Journal:  Int Wound J       Date:  2017-12-15       Impact factor: 3.315

3.  Maintenance of the Results of Stage II Lower Limb Lymphedema Treatment after Normalization of Leg Size.

Authors:  Jose Maria Pereira de Godoy; Henrique Jose Pereira de Godoy; Renata Lopes Pinto; Fernando Nestor Facio; Maria de Fatima Guerreiro Godoy
Journal:  Int J Vasc Med       Date:  2017-08-01

Review 4.  Indications for medical compression stockings in venous and lymphatic disorders: An evidence-based consensus statement.

Authors:  Eberhard Rabe; Hugo Partsch; Juerg Hafner; Christopher Lattimer; Giovanni Mosti; Martino Neumann; Tomasz Urbanek; Monika Huebner; Sylvain Gaillard; Patrick Carpentier
Journal:  Phlebology       Date:  2017-02-22       Impact factor: 1.740

5.  Effects of preventive use of compression stockings for elderly with chronic venous insufficiency and swollen legs: a systematic review and meta-analysis.

Authors:  Kristin Thuve Dahm; Hilde Tinderholt Myrhaug; Hilde Strømme; Brynjar Fure; Kjetil Gundro Brurberg
Journal:  BMC Geriatr       Date:  2019-03-07       Impact factor: 3.921

6.  The ICC Compression Questionnaire: A Comprehensive Tool to Evaluate Compression Materials or Devices Applied in Subjects with Lymphedema or Chronic Venous Disease.

Authors:  Nele Devoogdt; Hugo Partsch; An-Kathleen Heroes; Tessa De Vrieze; An De Groef; Inge Geraerts; Robert J Damstra; Juerg Hafner; Vaughan Keeley; Anja Becker; Giovanni Mosti; Els Brouwer; Sarah Thomis
Journal:  Lymphat Res Biol       Date:  2021-03-30       Impact factor: 2.589

7.  The effects of short-term use of compression stockings on health related quality of life in patients with chronic venous insufficiency.

Authors:  Özlem Cinar Özdemir; Serkan Sevim; Elif Duygu; Alper Tuğral; Yesim Bakar
Journal:  J Phys Ther Sci       Date:  2016-07-29

8.  Graduated compression stockings for the initial treatment of varicose veins in people without venous ulceration.

Authors:  Sarah L Knight Nee Shingler; Lindsay Robertson; Marlene Stewart
Journal:  Cochrane Database Syst Rev       Date:  2021-07-16

Review 9.  Medical compression therapy of the extremities with medical compression stockings (MCS), phlebological compression bandages (PCB), and medical adaptive compression systems (MAC) : S2k guideline of the German Phlebology Society (DGP) in cooperation with the following professional associations: DDG, DGA, DGG, GDL, DGL, BVP.

Authors:  E Rabe; E Földi; H Gerlach; M Jünger; G Lulay; A Miller; K Protz; S Reich-Schupke; T Schwarz; M Stücker; E Valesky; F Pannier
Journal:  Hautarzt       Date:  2021-01-01       Impact factor: 0.751

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.